A blood test that measures circulating tumor DNA can identify patients with colorectal cancer who may derive the most benefit from adjuvant chemotherapy.
Glioblastomas can be identified as a result of an incidental MRI finding. A study of 234 patients found four tumors. The study was published as a preprint and has not yet been peer reviewed.